Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Post-Election Industry Outlook: New User Fees, More Aggressive FDA

This article was originally published in The Gray Sheet

Executive Summary

With a Democrat-controlled government led by President-elect Barack Obama poised to take control, industry experts have begun speculating on the future of device regulation and reimbursement
Advertisement

Related Content

People In Brief
People In Brief
GOP Lawmakers Signal FDA Won’t Escape Congressional Crosshairs In 2009
GOP Lawmakers Signal FDA Won’t Escape Congressional Crosshairs In 2009
Obama Wants Comparative Effectiveness Institute; Is NICE A Good Model?
Extra Caution Needed In Uncertain Period For Off-Label Info Distribution
Senate Crafts Import Safety Bill, As Device Reps Prep For House Hearing
Senate Crafts Import Safety Bill, As Device Reps Prep For House Hearing
Draft Bill Would Overrule Supreme Court’s Device Pre-emption Support
Advertisement
UsernamePublicRestriction

Register

MT026777

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel